Integrating bulk and single‐cell data to predict the prognosis and identify the immune landscape in HNSCC
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Chunlong Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China. Hauptthemen laut MEDLINE: Endothelial Cells, Head and Neck Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
The complex interplay between tumour cells and the tumour microenvironment (TME) underscores the necessity for gaining comprehensive insights into disease progression. This study centres on elucidating the elusive the elusive role of endothelial cells within the TME of head and neck squamous cell carcinoma (HNSCC). Despite their crucial involvement in angiogenesis and vascular function, the mechanistic diversity of endothelial cells among HNSCC patients remains largely uncharted. Leveraging advanced single‐cell RNA sequencing (scRNA‐Seq) technology and the Scissor algorithm, we aimed to bridge this knowledge gap and illuminate the intricate interplay between endothelial cells and patient prognosis within the context of HNSCC. Here, endothelial cells were categorized into Scissor high and Scissor low subtypes. We identified Scissor + endothelial cells exhibiting pro‐tumorigenic profiles and constructed a prognostic risk model for HNSCC. Additionally, four biomarkers also were identified by analysing the gene expression profiles of patients with HNSCC and a prognostic risk prediction model was constructed based on these genes. Furthermore, the correlations between endothelial cells and prognosis of patients with HNSCC were analysed by integrating bulk and single‐cell sequencing data, revealing a close association between SHSS and the overall survival (OS) of HNSCC patients with malignant endothelial cells. Finally, we validated the prognostic model by RT‐qPCR and IHC analysis. These findings enhance our comprehension of TME heterogeneity at the single‐cell level and provide a prognostic model for HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
- Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, China.
ORCID-Profile: Chunlong Yang, Qingjun Pan
Förderung
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Yang, C., Cheng, X., Gao, S., & Pan, Q. (2024). Integrating bulk and single‐cell data to predict the prognosis and identify the immune landscape in HNSCC. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18009
Vancouver
Yang C, Cheng X, Gao S, Pan Q. Integrating bulk and single‐cell data to predict the prognosis and identify the immune landscape in HNSCC. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18009
BibTeX
@article{Yang2024,
author = {Yang, Chunlong and Cheng, Xiaoning and Gao, Shenglan and Pan, Qingjun},
title = {Integrating bulk and single‐cell data to predict the prognosis and identify the immune landscape in HNSCC},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18009}
}
EUVIMED